Targeted transperineal biopsy of the prostate has limited additional benefit over background cores for larger MRI-identified tumors.

To compare histological outcomes in patients undergoing MRI-transrectal ultrasound fusion transperineal (MTTP) prostate biopsy and determine the incremental benefit of targeted cores.

Seventy-six consecutive patients with 89 MRI-identified targets underwent MTTP biopsy.

Separate targeted biopsies and background cores were obtained according to a standardized protocol Target biopsies were considered of added diagnostic value if these cores showed a higher Gleason grade than non-targeted cores taken from the same sector (Group 1, n = 41) Conversely, where background cores demonstrated an equal or higher Gleason grade, target cores were considered to be non-beneficial (Group 2, n = 48)

There was no significant difference in age, PSA, prostate volume, time-to-biopsy, and number of cores obtained between the groups A greater proportion of target cores were positive for cancer (158/228; 69 3 %) compared to background (344/1881; 18 38 %) The median target volume was 0 54 cm(3) for Group 1 (range 0 09-2 79 cm(3)) and 1 65 cm(3) for Group 2 (0 3-9 07 cm(3)), p < 0 001 The targets in Group 1 had statistically lower diameters for short and long axes, even after correction for gland size The highest area under the receiver operating characteristic curve was demonstrated when a lesion cutoff value of 1 0 cm in short axis was applied, resulting in a sensitivity of 83 3 % and a specificity of 82 9 %

When a combined systematic and targeted transperineal prostate biopsy is performed, there is limited benefit in acquiring additional cores from larger-volume targets with a short axis diameter >1 0 cm

World journal of urology 2015 Aug 04 [Epub ahead of print]

Tristan Barrett, Andrew J Patterson, Brendan C Koo, Karan Wadhwa, Anne Y Warren, Andrew Doble, Vincent J Gnanapragasam, Christof Kastner, Ferdia A Gallagher

Department of Radiology, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK, tristan  

PubMed

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe